The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Rising to the rare disease challenge: Key considerations in large-molecule orphan drug development
Whitepaper
Rare diseases present a unique set of challenges within drug development due to small-scale manufacturing, limited time/data, small sample sizes, and costs. Learn how to overcome these challenges with:
- Process design decisions for clinical batches across the three stages of validation
- Key formulation considerations for sterile dosage forms based on the physical, chemical, and biologic characteristics of the drug substances
- Optimal API quantities for preclinical development and phase I studies